Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial-Reference-Cited by-同舟云学术

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial

Published:2018-07-10 Issue:1 Volume:16 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Syn Nicholas L.,Wong Andrea Li-Ann,Lee Soo-Chin,Teoh Hock-Luen,Yip James Wei Luen,Seet Raymond CS,Yeo Wee Tiong,Kristanto William,Bee Ping-Chong,Poon LM,Marban Patrick,Wu Tuck Seng,Winther Michael D.,Brunham Liam R.,Soong Richie,Tai Bee-Choo,Goh Boon-Cher

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12916-018-1093-8.pdf

Reference29 articles.

1. Passman R. Time in therapeutic range in warfarin-treated patients: is very good good enough? JAMA. 2016;316:872.

2. Pokorney SD, Simon DN, Thomas L, Gersh BJ, Hylek EM, Piccini JP, et al. Stability of international normalized ratios in patients taking long-term warfarin therapy. JAMA. 2016;316:661.

3. Jonas DE, McLeod HL. Genetic and clinical factors relating to warfarin dosing. Trends Pharmacol Sci. 2009;30:375–86.

4. Johnson JA, Cavallari LH. Warfarin pharmacogenetics. Trends Cardiovasc Med. 2015;25:33–41.

5. Syn NL-X, Yong W-P, Lee S-C, Goh B-C. Genetic factors affecting drug disposition in Asian cancer patients. Expert Opin Drug Metab Toxicol. 2015;11:1879–92.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics: An Update Review;International Journal of Innovative Science and Research Technology (IJISRT);2024-07-11

2. Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial;Annals of Hematology;2024-04-18

3. A Survey on Optimization and Machine Learning-Based Fair Decision Making in Healthcare;2024-03-18

4. Molecular diagnostics for coagulopathies;Diagnostic Molecular Pathology;2024

5. Patient-Level Exposure to Actionable Pharmacogenomic Medications in a Nationally Representative Insurance Claims Database;Journal of Personalized Medicine;2023-11-03